Protein-based Cas9 in vivo gene editing therapeutics have practical limitations owing to their instability and low efficacy. To overcome these obstacles and improve stability, we designed a nanocarrier primari...
from Most Recent Articles: Journal of Nanobiotechnology http://bit.ly/2BbG46H
via IFTTT
No comments:
Post a Comment